Page last updated: 2024-09-03

3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Cerebral Infarction, Middle Cerebral Artery

3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Cerebral Infarction, Middle Cerebral Artery in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hagg, T; Kang, SS; Keasey, MP1
Hirayama, Y; Koizumi, S1
Hide, I; Kitamura, Y; Nakata, Y; Takata, K; Taniguchi, T; Yanagisawa, D1
Arbeloa, J; Gottlieb, M; Matute, C; Pérez-Samartín, A1

Other Studies

4 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
P2X7 receptor inhibition increases CNTF in the subventricular zone, but not neurogenesis or neuroprotection after stroke in adult mice.
    Translational stroke research, 2013, Volume: 4, Issue:5

    Topics: Adenosine Triphosphate; Affinity Labels; Animals; Ciliary Neurotrophic Factor; Cytokines; Disease Models, Animal; Indicators and Reagents; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neurogenesis; Neuroprotective Agents; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes; Stroke

2013
Hypoxia-independent mechanisms of HIF-1α expression in astrocytes after ischemic preconditioning.
    Glia, 2017, Volume: 65, Issue:3

    Topics: Adenosine Triphosphate; Animals; Astrocytes; Brain; Cells, Cultured; Disease Models, Animal; Functional Laterality; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Infarction, Middle Cerebral Artery; Ischemic Preconditioning; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Phosphopyruvate Hydratase; Platelet Aggregation Inhibitors; Receptors, Purinergic P2X7

2017
Possible involvement of P2X7 receptor activation in microglial neuroprotection against focal cerebral ischemia in rats.
    Biological & pharmaceutical bulletin, 2008, Volume: 31, Issue:6

    Topics: Adenosine Triphosphate; Animals; CD11b Antigen; Fluorescent Antibody Technique, Indirect; Glial Fibrillary Acidic Protein; Immunohistochemistry; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Ischemic Attack, Transient; Male; Microglia; Motor Activity; Postural Balance; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P2X7

2008
P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia.
    Neurobiology of disease, 2012, Volume: 45, Issue:3

    Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Brain Injuries; Calcium; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Agonists; Fluoresceins; Glucose; Hypoxia; In Vitro Techniques; Infarction, Middle Cerebral Artery; Membrane Potentials; N-Methylaspartate; Neurologic Examination; Neurons; Organic Chemicals; Patch-Clamp Techniques; Phosphopyruvate Hydratase; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Tetrazolium Salts

2012